Literature DB >> 27022409

Overview: referrals for genetic evaluation from child psychiatrists.

Katharine R Press1, Laura Wieczorek2, Julie Hoover-Fong3, Joann Bodurtha3, Lynn Taylor4.   

Abstract

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. For numerous reasons, it is important to identify a genetic etiology in child psychiatry patients when it is present. Genetic diagnoses can guide treatment and enable access to specialized clinics and appropriate screening measures. They can also allow for genetic counseling for the patient and family. A better understanding of etiology with a named diagnosis can itself be of great value to many patients and families; prognostic information can be empowering. Since patients with genetic conditions may present to psychiatric care in diverse ways, child psychiatrists must decide who to refer for genetic evaluation. Here we create a table to provide a framework of concerning/notable history and exam features that a practicing child psychiatrist may encounter that should prompt one to consider whether a larger, unifying genetic diagnosis is at hand. We hope this framework will facilitate referral of child psychiatry patients to genetics so that more patients can benefit from an appropriate diagnosis.

Entities:  

Keywords:  Child psychiatry; Diagnosis; Genetics

Year:  2016        PMID: 27022409      PMCID: PMC4809034          DOI: 10.1186/s13034-016-0095-6

Source DB:  PubMed          Journal:  Child Adolesc Psychiatry Ment Health        ISSN: 1753-2000            Impact factor:   3.033


Background

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. The prevalence of genetic diagnoses among child psychiatry patients is best studied for autism, where 10–20 % of cases have a diagnosable genetic cause [e.g. Fragile X (FXS)] [1-6]. There is little information about the prevalence of genetic conditions in child psychiatry patients more generally. There are a large number of different genetic conditions that may lead to psychiatric presentation in a child. A December 2015 search of the Online Mendelian Inheritance in Man database (OMIM.org®), a catalog of genetic conditions, reveals 42 genetic etiologic associations for both psychiatric symptoms and autism. As genetic understanding continues to progress, the overlap with child psychiatry grows and it becomes increasingly important for child psychiatrists to recognize signs of a possible underlying genetic diagnoses [7]. In some instances, a genetic condition may have a typical psychiatric presentation and psychiatric symptoms may appear isolated. In such cases, presentation may be indistinguishable from that of a typical psychiatric patient whose disease is polygenic and multifactorial and genetic diagnosis is more difficult [8]. However, in many cases a genetic etiology may be suggested by features of history or physical exam. If child psychiatrists are aware of red flags signifying possible genetic condition, more patients can be appropriately diagnosed. This article addresses two questions: Why is it important to diagnose genetic conditions in child psychiatry patients? What should prompt a child psychiatrist to request a genetic consult for a patient?

Main text

Benefits of diagnosing genetic conditions

Identifying a genetic etiology in child psychiatry patients has many benefits [9]. Diagnosis of specific genetic conditions can guide treatment and allow access to specialized healthcare. For example, depression may herald Wilson disease, which can be effectively treated with chelators [10]. In metabolic disorders with psychiatric symptoms, a diagnosis can allow for appropriate management to avoid metabolic decompensations, which worsen both psychiatric and somatic symptoms [8]. In children with FXS, hyperactivity responds particularly well to methylphenidate. Hyperactivity is more responsive to methylphenidate as part of FXS versus part of autism spectrum disorder or intellectual disability, or possibly even non-specific ADHD [3]. When diagnosed, these patients can be put directly on methylphenidate and avoid many medication trials, which carry associated risks. Furthermore, because psychiatric symptoms may arise years before more specific organic signs, certain treatments may be more effective at the ‘psychiatric stage’ before occurrence of irreversible lesions. This is particularly true for metabolic disorders [11]. Genetic diagnosis also enables access to specialized clinics with greater understanding of and experience with these complex presentations [12]. There are a growing number of condition-specific and neurogenetic clinics that may be very beneficial to patients. Because wait times to appointments can be challenging, other consultation strategies (e.g. telehealth) may be considered. Additionally, some genetic conditions are associated with known medical complications and may require routine screening or further medical work-up. For example, a patient presenting with autism spectrum disorder and macrocephaly who is found to have a PTEN mutation can then be enrolled in a cancer screening protocol. Further, diagnosis can allow for appropriate genetic counseling for the patient and family [12, 13]. Finally, a better understanding of etiology with a named diagnosis may itself be of great value to many. Most individuals would rather know they have a serious disease than continue without a diagnosis [14]. Diagnosis allows for improved understanding, educational planning, and social support, and peer networking [15, 16]. Prognostic information can be empowering.

Indications for genetic consultation

It is not practical to conduct a genetic workup on all patients, so child psychiatrists must decide whom to refer for genetic evaluation [1]. Child psychiatrists are in an important position to diagnose genetic conditions, as they often see children for whom a diagnosis has been elusive, who have unusual presentations, or who have been difficult to treat. Patients with genetic conditions may present to psychiatric care in diverse ways. Table 1 shows genetic conditions that may in rare cases account for typical child psychiatry presentations. Psychiatric symptoms may be apparently isolated, making genetic diagnosis difficult. However, often a careful history and physical provides hints to a genetic diagnosis.
Table 1

Genetic syndromes may in rare cases manifest in more general child psychiatry presentations

Psychiatric presentationExample of genetic syndrome that may result in this presentation
Anxiety22q11 deletion [17], Fragile X syndrome [18], Williams syndrome [19]
Acute psychosisAdrenoleukodystrophy [20], Porphyria [21], Niemann-Pick [21], 22q11 deletion [17]
Conduct disorder/poor judgment/angerMonoamine oxidase A deficiency [22]
HyperactivityTurner syndrome [23], Fragile X syndrome [3]
DepressionWilson disease [24]
Genetic syndromes may in rare cases manifest in more general child psychiatry presentations Some unusual psychiatric presentations or behaviors may suggest a particular genetic etiology. Skin picking may occur in Prader-Willi syndrome [25] while severe disruptions of sleep and nail pulling suggest Smith-Magenis syndrome [26]. In many cases, non-psychiatric features of the history or exam will provide clues to genetic etiology. The purpose of Table 2 is to present a framework of notable history and exam features that should prompt a child psychiatrist to consider whether there is a larger, unifying genetic diagnosis at hand. All of these features are recognized as markers in pediatric genetic practice, however here the goal is to isolate the flags most likely to present in a child psychiatry practice [27]. This table is just a starting point and should not be considered exhaustive.
Table 2

Red flags for a possible genetic diagnosis in child psychiatry patients

Red flagExplanationExamples of genetic conditions that may include specific psychiatric components
Medical history
 Autism spectrum disorderGenetic causes can be identified in 10–20 % of autism patients [16]Rett syndromePTEN mutationsTuberous sclerosisChromosomal copy number variants
 Intellectual disability or global developmental delayWhile these findings may be purely developmental, they should be investigated further when the findings seem out of proportion to the level of developmental delayRett syndromefragile X
 Psychiatric symptoms worsening with conditions leading to increased protein catabolism, such as fever, surgery, or prolonged fastingMay indicate metabolic dysfunction
 Unusually severe presentation or prolonged recovery after minor illnessAcute intermittent porphyria
 Cyclic or recurrent vomiting, particularly with protein intakeOrganic acidemiasInborn error in pyruvate metabolism
 Poor or atypical treatment response to medications or behavioral interventionsMay indicate an alternate or additional diagnosis to explain nonstandard response/componentsPrader-Willi syndrome
 Severely disrupted sleepSmith-Magenis syndrome
 Self-injurious behavior or skin pickingLesch-Nyhan syndrome, Prader-Willi syndrome
Family history
 Significant family history of psychiatric conditionsThough purely psychiatric conditions may also follow a familial pattern, this could indicate an underlying genetic diagnosis22q11 deletion syndrome
 Significant family history of neurologic regression or progressive neurologic disordersMay represent certain autosomal dominant traits for which first symptoms are sometimes psychiatricHuntington diseaseSpinocerebellar ataxias
 Family history of relatives with intellectual disabilities or many with learning disabilitiesIntellectual disability and learning disabilities are part of many genetic syndromes that also have psychiatric featuresFragile X syndrome
 Born to a parent with a known cytogenetic abnormality (e.g. balanced translocation) or recurrent pregnancy lossTranslocations may become unbalanced in subsequent generations causing a variety of presentations including psychiatric disease and pregnancy lossUnbalanced chromosomal complement
Physical exam
 Dysmorphic features that are not familialMay be caused by genetic syndrome22q11 deletion syndromeFragile XSubmicroscopic chromosomal deletions and duplicationsLysosomal storage diseases
 Single major or multiple minor and/or major physical anomaliesBranchio-oto-renal syndromeHolt Oram syndromeChromosomal deletions or deletions
 Striking inability to learn after many well-controlled trialsMay suggest cortical dysfunctionFragile X
 HepatosplenomegalyThese findings would not be explained by a psychiatric diagnosis alone. In conjunction with psychiatric symptoms, these findings may suggest a unifying genetic diagnosis.Gaucher diseaseNiemann-Pick diseaseMucopolysaccharidoses
 Unusual body odorGlutaric aciduria type IIPhenylketonuriaIsovaleric academiaMaple syrup urine disease
 Unusual dermatologic findings: multiple types of lesions, six or more café au lait macules >1.5 cm in diameter, multiple lipomas, albinismNeurofibromatosis type ICowden syndromeHermansky-Pudlak syndrome
 Unexplained neurologic findings  Intractable seizures  Hypertonia or hypotonia  Peripheral neuropathy  Myopathy  Progressive ataxiaGaucher diseaseNeuronal ceroid lipofuscinosisMitochondrial disordersInborn errors of metabolism including leukodystrophiesPrader-Willi syndromeAngelman syndrome Charcot-Marie-Tooth diseaseSpinocerebellar ataxias
 Evidence of a connective tissue disorder  Joint laxity  Poor wound healing  Marfanoid habitusHomocystinuriaEhlers Danlos syndrome
 Unexplained lab anomalies  Acidosis  Persistent hypoglycemia  Adrenal insufficiencyOrganic acidemiasBeckwith-Wiedemann syndromeAdrenoleukodystrophy
 Abnormal brain MRI findingsTuberous sclerosisLeukodystrophiesSpinocerebellar ataxias, Alexander disease
 MicrocephalyFetal alcohol syndrome, Williams syndrome
 Failure to thrive or short statureWhile psychiatric illness may lead to growth abnormalities, these abnormalities should be evaluated further when they cannot be fully explained by psychiatric diseaseVarious chromosomal conditions
Red flags for a possible genetic diagnosis in child psychiatry patients If one or more of these red flags are present, a child psychiatrist should consider requesting a genetic consultation. Whenever possible, genetic tests should be ordered in conjunction with a genetic team. On a practical level, determining which genetic tests to order can be confusing and outside the usual practice of most child psychiatrists. Even more important, many child psychiatrists are not comfortable explaining the intricacies of genetic testing and lack the infrastructure to deal with ramifications of positive results [28]. Informed consent must include discussion of the risks of genetic testing, which include harms associated with resultant treatments and incidental findings that can be life changing or psychologically disruptive [29]. There may be particular cases in which a child psychiatrist has experience with or training relevant to a certain genetic test and feels comfortable ordering this test, so this remains an individual call. However, in most cases it is best to involve a genetic team and employ their associated infrastructure. It is our hope that this table will help child psychiatrists communicate with genetic teams by allowing them to pinpoint the red flags that led them to consider a genetic etiology.

Conclusions

It is important to identify a genetic etiology in child psychiatry patients when it is present, as it has implications for treatment and counseling. Patients with genetic conditions may have unusual psychiatric symptoms or other abnormal history and physical findings. Here we present a table of red flags that a practicing child psychiatrist may identify, which could indicate an underlying genetic diagnosis. We hope this table will inspire child psychiatrists to think about genetic possibilities in their patient populations and make referrals for genetic evaluation when appropriate. Future work will be needed to validate this table in practice. However, being aware of these the flags has immediate utility in the clinical practice of child psychiatrists. To highlight how simple practice changes may have a big impact for diagnosing conditions, we provide a short list of tips and resources for making a genetic diagnosis in child psychiatry (Table 3). We hope that this commentary will encourage child psychiatrists to think about their growing overlap with the field of genetics. Recognition of the importance of genetic diagnoses in child psychiatry patients may stimulate more research into the prevalence of genetic disease, effective methods of screening and diagnosis, and strategies for treatment and management for these patients.
Table 3

Short list of tips and resources for making genetic diagnoses in child psychiatry

1.Take a family history
2.Measure and plot head circumference percentiles
3.Inspect the skin
4.Take note of dysmorphic features
5.Know your genetics referral colleagues
6.Short list of genetic resources GeneReviews®: http://www.genereviews.org/  Online Mendelian Inheritance in Man (OMIM)®: http://www.omim.org/  Genetics Home Reference: http://ghr.nlm.nih.gov/
Short list of tips and resources for making genetic diagnoses in child psychiatry
  27 in total

1.  Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders.

Authors:  Marian Reiff; Ellen Giarelli; Barbara A Bernhardt; Ebony Easley; Nancy B Spinner; Pamela L Sankar; Surabhi Mulchandani
Journal:  J Autism Dev Disord       Date:  2015-10

Review 2.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

Review 3.  The genetics of mental illness: implications for practice.

Authors:  S E Hyman
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

Review 4.  Neurologic manifestations, diagnosis and management of Wilson's disease in children - an update.

Authors:  S T Alam; M M Rahman; K A Islam; Z Ferdouse
Journal:  Mymensingh Med J       Date:  2014-01

Review 5.  Fragile X syndrome.

Authors:  Wilmar Saldarriaga; Flora Tassone; Laura Yuriko González-Teshima; Jose Vicente Forero-Forero; Sebastián Ayala-Zapata; Randi Hagerman
Journal:  Colomb Med (Cali)       Date:  2014-12-30

Review 6.  Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults.

Authors:  F Sedel; N Baumann; J-C Turpin; O Lyon-Caen; J-M Saudubray; D Cohen
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

7.  Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects.

Authors:  Heather F Russell; Deeann Wallis; Michèle M M Mazzocco; Thomas Moshang; Elaine Zackai; Andrew R Zinn; Judith L Ross; Maximilian Muenke
Journal:  J Pediatr Psychol       Date:  2006-03-08

8.  Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?

Authors:  Manuel Schiff; Jean-François Benoist; Sofiane Aïssaoui; Odile Boespflug-Tanguy; Odile Boepsflug-Tanguy; Marie-Christine Mouren; Hélène Ogier de Baulny; Richard Delorme
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

9.  Treatment effects of stimulant medication in young boys with fragile X syndrome.

Authors:  Jane E Roberts; Margot Miranda; Maria Boccia; Heather Janes; Bridgette L Tonnsen; Deborah D Hatton
Journal:  J Neurodev Disord       Date:  2011-06-14       Impact factor: 4.025

Review 10.  Psychiatric manifestations of treatable hereditary metabolic disorders in adults.

Authors:  Caroline Demily; Frédéric Sedel
Journal:  Ann Gen Psychiatry       Date:  2014-09-24       Impact factor: 3.455

View more
  1 in total

1.  Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome.

Authors:  Lisa D Palmer; Nancy J Butcher; Erik Boot; Kathleen A Hodgkinson; Tracy Heung; Eva W C Chow; Alina Guna; T Blaine Crowley; Elaine Zackai; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-04       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.